Amazing new member to their Board of Directors--HUGE news
ADMD has added one of the region's top medical device entrepreneurs, Thomas J. Clement, to the Board of Directors. Clement has over 30 years experience in product development engineering, engineering management, and senior management. He was a founding employee of Heart Technology, which grew to more than $100 million in revenue and was acquired by Boston Scientific. In 1998 Clement co-founded Pathway Medical Technologies, Inc. Serving as CEO, he successfully raised more than $84 million. Pathway was acquired by Bayer Healthcare of Germany in 2011.
Tom Clement has recently held the positions of Chairman of the Washington State Biotechnology and Biomed Association (WBBA) as well as the Director of New Ventures-Life Sciences for the University of Washington's Center for Commercialization. Tom is currently the CEO of two start-up companies, Cardiac Insight, Inc., and Aqueduct Neurosciences, Inc. and is on the Board of Directors of several medical technology companies.
Further, Mr. Clement serves as a Governor appointed Board member for the Washington Global Health Fund and an Advisory Board Member on the Visiting Committee for the University of Washington's Educational Outreach Programs. Clement has a Master of Science in Electrical Engineering from the University of Washington, and an Executive MBA from Stanford.--HUG
This was some good bit of news. I got out of ADMD for a while but now I am back in-- as this is a really good time to invest again. The stock has been dwindling making it a great time to accumulate--because the truth is that the stock is VERY undervalued. With all the positives in the works for this little company, the potential and possibility of great returns from the various aspects of its business model is evident to me.